The $80 Billion Question: Can Genentech’s 2020 Numbers Keep Climbing?
The $80 Billion Question: Can Genentech’s 2020 Numbers Keep Climbing? Genentech, a subsidiary of Roche Pharmaceuticals, has been making headlines in the biotech industry with its unprecedented growth over the past few…
Read more → The $80 Billion Question: Can Genentech’s 2020 Numbers Keep Climbing?
